Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

Feldmann And Maini Win Paul Janssen Award For Biomedical Research

by Linda Wang
August 25, 2008 | A version of this story appeared in Volume 86, Issue 34

MARC FELDMANN, professor and head of the Kennedy Institute of Rheumatology (KIR), Imperial College London, and Sir Ravinder N. Maini, emeritus professor also at KIR, have been named the recipients of the 2008 Dr. Paul Janssen Award for Biomedical Research.

The award, created by Johnson & Johnson, salutes “the most passionate and creative scientists in basic or clinical research, whose scientific achievements have made, or have strong potential to make, a measurable impact on human health.”

Feldmann and Maini were selected for their roles in the discovery of tumor necrosis factor α as an effective therapeutic target for rheumatoid arthritis and other chronic inflammatory conditions that afflict millions of people worldwide. The award, which includes a $100,000 prize, will be presented on Sept. 10.

This section is compiled by Linda Wang. Announcements of awards may be sent to a l_wang@acs.org.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.